Serena Landini

1.8k total citations
10 papers, 388 citations indexed

About

Serena Landini is a scholar working on Genetics, Molecular Biology and Pharmacology. According to data from OpenAlex, Serena Landini has authored 10 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Serena Landini's work include Estrogen and related hormone effects (5 papers), Inflammatory mediators and NSAID effects (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Serena Landini is often cited by papers focused on Estrogen and related hormone effects (5 papers), Inflammatory mediators and NSAID effects (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Serena Landini collaborates with scholars based in United States and United Kingdom. Serena Landini's co-authors include Robert W. Brueggemeier, Bin Su, Edgar S. Díaz‐Cruz, David M. Livingston, Terrence L. Graham, Madge Y. Graham, Donna Neuberg, Kevin Eggan, Lisa Cameron and Sarah J. Hill and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Serena Landini

10 papers receiving 384 citations

Peers

Serena Landini
Jung‐Hoon Kang South Korea
C. Damodar Reddy United States
Jody K. Lancia United States
Aiying Du China
Zejin Sun United States
Rebecca Salmonsen United States
Jung‐Hoon Kang South Korea
Serena Landini
Citations per year, relative to Serena Landini Serena Landini (= 1×) peers Jung‐Hoon Kang

Countries citing papers authored by Serena Landini

Since Specialization
Citations

This map shows the geographic impact of Serena Landini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Landini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Landini more than expected).

Fields of papers citing papers by Serena Landini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Landini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Landini. The network helps show where Serena Landini may publish in the future.

Co-authorship network of co-authors of Serena Landini

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Landini. A scholar is included among the top collaborators of Serena Landini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Landini. Serena Landini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hatchi, Elodie, Liana Goehring, Serena Landini, et al.. (2021). BRCA1 and RNAi factors promote repair mediated by small RNAs and PALB2–RAD52. Nature. 591(7851). 665–670. 35 indexed citations
2.
Hill, Sarah J., Daniel A. Mordes, Lisa Cameron, et al.. (2016). Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proceedings of the National Academy of Sciences. 113(48). E7701–E7709. 100 indexed citations
3.
Neupane, Manish, Allison Clark, Serena Landini, et al.. (2015). MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy. Cancer Discovery. 6(1). 45–58. 49 indexed citations
4.
Su, Bin, Edgar S. Díaz‐Cruz, Serena Landini, & Robert W. Brueggemeier. (2007). Suppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition. Steroids. 73(1). 104–111. 22 indexed citations
5.
Díaz‐Cruz, Edgar S., et al.. (2007). Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 108(1-2). 23–31. 33 indexed citations
6.
Su, Bin, et al.. (2007). Synthesis and Biological Evaluation of Selective Aromatase Expression Regulators in Breast Cancer Cells. Journal of Medicinal Chemistry. 50(7). 1635–1644. 33 indexed citations
7.
Su, Bin, Edgar S. Díaz‐Cruz, Serena Landini, & Robert W. Brueggemeier. (2006). Novel Sulfonanilide Analogues Suppress Aromatase Expression and Activity in Breast Cancer Cells Independent of COX-2 Inhibition. Journal of Medicinal Chemistry. 49(4). 1413–1419. 38 indexed citations
8.
Balunas, Marcy J., Bin Su, Serena Landini, Robert W. Brueggemeier, & A. Douglas Kinghorn. (2006). Interference by Naturally Occurring Fatty Acids in a Noncellular Enzyme-Based Aromatase Bioassay. Journal of Natural Products. 69(4). 700–703. 22 indexed citations
9.
Landini, Serena, Madge Y. Graham, & Terrence L. Graham. (2003). Lactofen induces isoflavone accumulation and glyceollin elicitation competency in soybean. Phytochemistry. 62(6). 865–874. 36 indexed citations
10.
Landini, Serena, et al.. (2002). Induced distal defence potentiation against Phytophthora sojae in soybean. Physiological and Molecular Plant Pathology. 60(6). 293–310. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026